Terrie Curran
2021
In 2021, Terrie Curran earned a total compensation of $6.3M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $396,257 |
|---|---|
| Option Awards | $5,294,273 |
| Salary | $567,500 |
| Other | $14,625 |
| Total | $6,272,655 |
Curran received $5.3M in option awards, accounting for 84% of the total pay in 2021.
Curran also received $396.3K in non-equity incentive plan, $567.5K in salary and $14.6K in other compensation.
Rankings
In 2021, Terrie Curran's compensation ranked 2,017th out of 12,415 executives tracked by ExecPay. In other words, Curran earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,017 out of 12,415 | 84th |
Division Manufacturing | 768 out of 5,505 | 86th |
Major group Chemicals And Allied Products | 299 out of 2,375 | 87th |
Industry group Drugs | 258 out of 2,096 | 88th |
Industry Pharmaceutical Preparations | 167 out of 1,546 | 89th |
Source: SEC filing on April 13, 2023.
Curran's colleagues
We found one more compensation record of an executive who worked with Terrie Curran at Phathom Pharmaceuticals in 2021.
2021
Azmi Nabulsi
Phathom Pharmaceuticals
Chief Operating Officer
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020